|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 31/00 | (2006.01) |
| A61K 31/4709 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/04 | (2006.01) | ||
| A61K 31/4745 | (2006.01) | ||
| A61K 31/517 | (2006.01) | ||
| A61K 31/519 | (2006.01) |
| (11) | Number of the document | 1255537 |
| (13) | Kind of document | T |
| (96) | European patent application number | 01905717.3 |
| Date of filing the European patent application | 2001-02-01 | |
| (97) | Date of publication of the European application | 2002-11-13 |
| (45) | Date of publication and mention of the grant of the patent | 2006-04-19 |
| (46) | Date of publication of the claims translation | 2006-08-25 |
| (86) | Number | PCT/EP2001/001032 |
| Date | 2001-02-01 |
| (87) | Number | WO 2001/056552 |
| Date | 2001-08-09 |
| (30) | Number | Date | Country code |
| 00200373 | 2000-02-04 | EP |
| (72) |
PALMER, Peter Albert, Janssen Pharmaceutica N.V, BE
HORAK, Ivan, David, US
|
| (73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Farnezilproteintransferazės slopintojai, skirti krūties vėžio gydymui |
| FARNESYL PROTEIN TRANSFERASE INHIBITORS FOR TREATING BREAST CANCER |
| Payment date | Validity (years) | Amount | |
| 2020-01-31 | 20 | 347.00 EUR |